About Event

Your One Stop Shop to CAR & TCR Therapies

The 8th CAR-TCR Summit is the world’s pre-eminent industry-leading comprehensive forum that unites the global cell therapy community across a variety of cell types (αβ T, γδ T, NK, NKT, Macrophage, TIL and more).

This is your opportunity to collaborate and network with industry pioneers, as the focus moves further towards conquering solid tumors and indications beyond oncology.  

End to End Updates Across 8 Tracks:

No matter what stage of development you're focusing on, there's 3 days of in-depth content for waiting for you at the 8th CAR-TCR Summit.

Discovery

Translation

Early Stage
Clinical Strategy

Clinical
Operations

Manufacturing

CMC & Analytics

Supply Chain & Logistics

Commercialization
& Market Access

More than Just a Meeting

In addition to the unrivalled scientific content in the form of presentations, panels and roundtable discussions, there's a variety of extra experiences that you can join including:

Drinks
Receptions

Tech
Slam

Breakfast
Briefings

EWF
Fun Run

Off-Site
Visits

“Very engaging and interactive program that allowed for learning new developments in the field. Relevant topics, high quality speakers, opportunity to network.”
James Chung, Chief Medical Officer, Kyverna Therapeutics

CAR-TCR-55
CAR-TCR-457
CAR-TCR-342

About the CAR-TCR Series

The CAR-TCR Event Series is committed to delivering an exclusive platform to unite the community and explore the key challenges to your industry, guided by global thought leaders in each discipline.

Dedicated to the development of safe, clinically effective and globally accessible therapies, the series is an unrivalled opportunity to gather with experts in your discipline.

From next-generation development to supply chain and logistics, and exploring challenges specific to each area, we create these forums to deliver value and in-depth learnings across the development pipeline, on a global stage.

Other Events in the Series:

“The most tightly focused CAR T-cell conference there is.”
Milos Miljkovic, Chief Medical Officer, Cartesian Therapeutics

Connect With Us to Stay Up to Date with the Field!

Join Our Twitter Following:

Join the LinkedIn Community:

Follow Us for the Latest CAR-TCR News: